Member of the Association of American Physicians
His primary areas of investigation include Internal medicine, Endocrinology, Growth factor, Insulin-like growth factor-binding protein and Somatomedin. His work on Insulin, Acromegaly, Growth hormone and Insulin-like growth factor as part of general Internal medicine research is often related to Nitrogen balance, thus linking different fields of science. His study ties his expertise on Insulin-like growth factor 2 together with the subject of Endocrinology.
His Growth factor research incorporates themes from Fibroblast, Autocrine signalling, Secretion and Cell biology. His Insulin-like growth factor-binding protein research integrates issues from Binding protein and Insulin-Like Growth Factor Binding Protein 6. His Somatomedin study combines topics from a wide range of disciplines, such as Epidermal growth factor, Liter, Extracellular fluid, Insulin blood and Sex factors.
His main research concerns Internal medicine, Endocrinology, Growth factor, Insulin-like growth factor and Insulin-like growth factor-binding protein. Cell type is closely connected to Cell growth in his research, which is encompassed under the umbrella topic of Internal medicine. His works in Insulin, Somatomedin, Diabetes mellitus, Growth hormone and Insulin resistance are all subjects of inquiry into Endocrinology.
In his research, Integrin is intimately related to Molecular biology, which falls under the overarching field of Growth factor. His Insulin-like growth factor-binding protein research incorporates elements of Cell culture and Insulin-like growth factor 2. His work on Amino acid, Fibroblast and Extracellular matrix as part of general Biochemistry study is frequently linked to Proteases, therefore connecting diverse disciplines of science.
David R. Clemmons mainly investigates Internal medicine, Endocrinology, Cell biology, Phosphorylation and Growth factor. David R. Clemmons usually deals with Internal medicine and limits it to topics linked to Antibody and Diabetic retinopathy. His Endocrinology research includes themes of Osteoblast and Insulin-like growth factor.
His Osteoblast research also works with subjects such as
David R. Clemmons spends much of his time researching Internal medicine, Endocrinology, Cell biology, Phosphorylation and Protein kinase B. His study in the field of Acromegaly and Leptin is also linked to topics like Context, Placebo and Osteocalcin. His Endocrinology research incorporates themes from Insulin-like growth factor and Osteoblast.
His Cell biology study combines topics in areas such as Growth factor and Cell growth. The study incorporates disciplines such as PI3K/AKT/mTOR pathway and Signal transduction in addition to Phosphorylation. As a part of the same scientific family, David R. Clemmons mostly works in the field of Diabetes mellitus, focusing on Antibody and, on occasion, Receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
John I. Jones;David R. Clemmons.
Endocrine Reviews (1995)
Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
Mark E. Molitch;David R. Clemmons;Saul Malozowski;George R. Merriam.
The Journal of Clinical Endocrinology and Metabolism (2006)
Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH research society
Kenneth M. Attie;Bengt Ake Bengtsson;Sandra L. Blethen;Werner Blum.
The Journal of Clinical Endocrinology and Metabolism (2000)
An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I.
R G Elgin;W H Busby;D R Clemmons.
Proceedings of the National Academy of Sciences of the United States of America (1987)
The insulin-like growth factors.
W. S. Cohick;David R Clemmons.
Annual Review of Physiology (1993)
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.
Trainer Pj;Drake Wm;Katznelson L;Freda Pu.
The New England Journal of Medicine (2000)
Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review
P Carroll;E R Christ;B A Bengtsson;L Carlsson.
The Journal of Clinical Endocrinology and Metabolism (1998)
Guidelines for Acromegaly Management: An Update
S. Melmed;A. Colao;A. Barkan;Mark E Molitch.
The Journal of Clinical Endocrinology and Metabolism (2009)
Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the growth hormone research society workshop on adult growth hormone deficiency
A. Attanasio;K. Attie;R. Baxter;B. A. Bengtsson.
The Journal of Clinical Endocrinology and Metabolism (1998)
Extracellular matrix contains insulin-like growth factor binding protein-5 : potentiation of the effects of IGF-I
John I. Jones;Amy Gockerman;Walker H. Busby;Cecilia Camacho-Hubner.
Journal of Cell Biology (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of North Carolina at Chapel Hill
Maine Medical Center
University of Pittsburgh
Harvard University
Cedars-Sinai Medical Center
Northwestern University
University of Virginia
University of Paris-Saclay
Harvard University
University of Michigan–Ann Arbor
University of Johannesburg
University of Montpellier
University of Glasgow
University of Tokyo
University of Toronto
European Commission
University of Reading
California Institute of Technology
National Oceanic and Atmospheric Administration
Boston University
University of Nebraska Medical Center
Boston Children's Hospital
National Institutes of Health
Vita-Salute San Raffaele University
Icahn School of Medicine at Mount Sinai
American University of Beirut